Global Oncology Radiopharmaceutical Supply, Demand and Key Producers, 2023-2029

Global Oncology Radiopharmaceutical Supply, Demand and Key Producers, 2023-2029

The global Oncology Radiopharmaceutical market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Oncology Radiopharmaceutical production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Oncology Radiopharmaceutical, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oncology Radiopharmaceutical that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Oncology Radiopharmaceutical total production and demand, 2018-2029, (K Units)

Global Oncology Radiopharmaceutical total production value, 2018-2029, (USD Million)

Global Oncology Radiopharmaceutical production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Oncology Radiopharmaceutical consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: Oncology Radiopharmaceutical domestic production, consumption, key domestic manufacturers and share

Global Oncology Radiopharmaceutical production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global Oncology Radiopharmaceutical production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Oncology Radiopharmaceutical production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)

This reports profiles key players in the global Oncology Radiopharmaceutical market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Chimeric Therapeutics Limited, Fusion Pharma, Lantheus Medical lmaging, Inc., NanoMab, NuView Life Sciences., PentixaPharm GmbHPrecirix, RadioMedix and RayzeBio, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oncology Radiopharmaceutical market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Oncology Radiopharmaceutical Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Oncology Radiopharmaceutical Market, Segmentation by Type
Oral Drugs
Intravenous Drugs
Other

Global Oncology Radiopharmaceutical Market, Segmentation by Application
Hospitals and Clinics
Pharmaceutical Company
Research Center
Other

Companies Profiled:
Novartis
Chimeric Therapeutics Limited
Fusion Pharma
Lantheus Medical lmaging, Inc.
NanoMab
NuView Life Sciences.
PentixaPharm GmbHPrecirix
RadioMedix
RayzeBio
Telix Pharmaceuticals Limited
Theragnostics Ltd
Vect-Horus

Key Questions Answered

1. How big is the global Oncology Radiopharmaceutical market?

2. What is the demand of the global Oncology Radiopharmaceutical market?

3. What is the year over year growth of the global Oncology Radiopharmaceutical market?

4. What is the production and production value of the global Oncology Radiopharmaceutical market?

5. Who are the key producers in the global Oncology Radiopharmaceutical market?

6. What are the growth factors driving the market demand?